Evidence map›Paper›PMID 39310221›Full record

ArticlePhysics and imaging in radiation oncology2024

Automated plan generation for prostate radiotherapy patients using deep learning and scripted optimization.

Cody Church, Michelle Yap, Mohamed Bessrour, Michael Lamey, Dal Granville

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Dosimetric benefits of half-field arc in prostate cancer treatment.Physical and engineering sciences in medicine · 2026
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cody ChurchDepartment of Medical Physics, The Ottawa Hospital General Campus, Canada.
Michelle YapDepartment of Medical Physics, The Ottawa Hospital General Campus, Canada.
Mohamed BessrourDepartment of Medical Physics, The Ottawa Hospital General Campus, Canada.
Michael LameyDepartment of Medical Physics, The Ottawa Hospital General Campus, Canada.
Dal GranvilleDepartment of Radiation Oncology and Department of Physics and Atmospheric Science, Dalhousie University, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Treatment planning is a time-intensive task that could be automated. We aimed to develop a "single-click" workflow, fully deployed within a commercial treatment planning system (TPS), for autoplanning prostate radiotherapy treatment plans using predictions from a deep learning model (DLM). Materials and Methods: Automatically generated treatment plans were created with a single script, executed from within a commercial TPS scripting environment, that performed two stages sequentially. Initially, a 3D dose distribution was predicted with a ResUNet DLM. The DLM was trained and validated using previously treated datasets (n = 120) which used 3D contours as inputs. Following this, dose predictions were converted into treatment plans by extracting dose-volume metrics from the predictions to use as objectives for the inverse optimizer within the TPS. An independent test dataset (n = 20) was used to evaluate the similarity between automated and clinical plans. Results: For planning target volumes, the median percentage difference and interquartile range between the automatically generated plans and clinical plans were 0.4% [0.2-1.1%] for the V Conclusions: An automatic plan generation workflow that uses a DL model with scripted optimization was fully deployed in a commercial TPS. Autoplans were compared to previously treated clinical plans and were found to be non-inferior.

Indexed as

AutoplanningDeep learningRadiotherapy

Identifiers

PMID39310221
PMCPMC11415801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.